It was Christmas come early for publicly funded TB programs and for advocates of improved tuberculosis regimens when the maker of a rifapentine, a drug that can shorten treatment for tuberculosis infection from as much as nine months to three months announced Thursday it will drop its price for the medicine to a dollar a […]
HIV
Since the president’s Feb. 5 State of the Union address pledge to end transmissions of HIV in the United States in the next 10 years, and […]
Tuberculosis
Releasing the most recent domestic and global data on tuberculosis incidence in this week’s Morbidity and Mortality Weekly Report, the U.S. Centers for Disease Control and […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
The following is a guest post by Emily Weaver, PhD, of MEASURE Evaluation Health projects and donors in low-resource countries increasingly aim to leverage existing data […]